Found: 56
Select item for more details and to access through your institution.
Correction: Zanubrutinib: past, present, and future.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Zanubrutinib: past, present, and future.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00902-x
- By:
- Publication type:
- Article
Zanubrutinib: past, present, and future.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00902-x
- By:
- Publication type:
- Article
Targeted Therapy in Leukaemia, Lymphoma and Myeloma.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 1, p. 74, doi. 10.3390/jpm12010074
- By:
- Publication type:
- Article
Breast Cancer-Related Lymphedema: Recent Updates on Diagnosis, Severity and Available Treatments.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 5, p. 402, doi. 10.3390/jpm11050402
- By:
- Publication type:
- Article
Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell Lymphomas.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 5, p. 355, doi. 10.3390/jpm11050355
- By:
- Publication type:
- Article
Targeted Therapies for Multiple Myeloma.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 5, p. 334, doi. 10.3390/jpm11050334
- By:
- Publication type:
- Article
Targeted Treatment of Follicular Lymphoma.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 2, p. 152, doi. 10.3390/jpm11020152
- By:
- Publication type:
- Article
Disseminated Enteroviral Infection Associated with Obinutuzumab.
- Published in:
- Emerging Infectious Diseases, 2015, v. 21, n. 9, p. 1661, doi. 10.3201/eid2109.150104
- By:
- Publication type:
- Article
Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Large cell lymphoma through a liquid lens.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 15, doi. 10.1111/bjh.19502
- By:
- Publication type:
- Article
Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. 790, doi. 10.1111/bjh.18306
- By:
- Publication type:
- Article
Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 5, p. 1209, doi. 10.1111/bjh.17994
- By:
- Publication type:
- Article
High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 6, p. 991, doi. 10.1111/bjh.14187
- By:
- Publication type:
- Article
The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 4, p. 576, doi. 10.1111/bjh.13151
- By:
- Publication type:
- Article
A consensus statement on the use of biosimilar medicines in hematology in Australia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 4, p. 211, doi. 10.1111/ajco.13337
- By:
- Publication type:
- Article
Management of patients with follicular lymphoma treated first line with obinutuzumab.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, p. 3, doi. 10.1111/ajco.13153
- By:
- Publication type:
- Article
WhiMSICAL: A global Waldenström's Macroglobulinemia patient‐derived data registry capturing treatment and quality of life outcomes.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. E218, doi. 10.1002/ajh.26173
- By:
- Publication type:
- Article
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Failure of eculizumab to correct paroxysmal cold hemoglobinuria.
- Published in:
- 2011
- By:
- Publication type:
- Letter
A case of ITP with cauda equina syndrome.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12589-9
- By:
- Publication type:
- Article
Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 7, p. 1223, doi. 10.1111/imj.16445
- By:
- Publication type:
- Article
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 6, p. 1017, doi. 10.1111/imj.16390
- By:
- Publication type:
- Article
Australian data on the utilisation and duration on treatment of ibrutinib with a proton pump inhibitor in patients with relapsed or refractory chronic lymphocytic leukaemia.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 11, p. 2115, doi. 10.1111/imj.16267
- By:
- Publication type:
- Article
Chronic lymphocytic leukaemia Australasian consensus practice statement.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 9, p. 1678, doi. 10.1111/imj.16207
- By:
- Publication type:
- Article
Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 12, p. 2172, doi. 10.1111/imj.15954
- By:
- Publication type:
- Article
Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experience.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 11, p. 1825, doi. 10.1111/imj.14965
- By:
- Publication type:
- Article
Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron‐deficiency anaemia: a Phase II single‐arm study.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 8, p. 1304, doi. 10.1111/imj.15195
- By:
- Publication type:
- Article
Author reply.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Front‐line management of indolent non‐Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma.
- Published in:
- Internal Medicine Journal, 2019, v. 49, n. 9, p. 1070, doi. 10.1111/imj.14268
- By:
- Publication type:
- Article
Front‐line management of non‐Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
- Published in:
- Internal Medicine Journal, 2019, v. 49, n. 4, p. 422, doi. 10.1111/imj.14113
- By:
- Publication type:
- Article
Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil.
- Published in:
- Internal Medicine Journal, 2017, v. 47, p. 5, doi. 10.1111/imj.13493
- By:
- Publication type:
- Article
Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2710, doi. 10.3390/cancers14112710
- By:
- Publication type:
- Article
High risk of infection in 'real‐world' patients receiving ibrutinib, idelalisib or venetoclax for mature B‐cell leukaemia/lymphoma.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 5, p. 540, doi. 10.1111/ejh.13928
- By:
- Publication type:
- Article
Clinical characteristics of Australian treatment‐naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 4, p. 386, doi. 10.1111/ejh.13915
- By:
- Publication type:
- Article
Long‐term outcomes of second‐line versus later‐line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18643, doi. 10.1002/cam4.6473
- By:
- Publication type:
- Article
Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49776-9
- By:
- Publication type:
- Article
Rituximab is associated with improved survival for aggressive B cell CNS lymphoma†.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 8, p. 1068, doi. 10.1093/neuonc/not032
- By:
- Publication type:
- Article
Interim Update from a Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor, in Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S278, doi. 10.1016/j.clml.2018.07.208
- By:
- Publication type:
- Article
Interim Report from a Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor: Clinical Activity and Favorable Safety in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S380, doi. 10.1016/j.clml.2017.07.227
- By:
- Publication type:
- Article
Burkitt lymphoma in the setting of common variable immunodeficiency.
- Published in:
- 2009
- By:
- Publication type:
- Letter
SEQUOIA: results of a phase 3 randomized study of Zanubrutinib versus Bendamustine + Rituximab (BR) in patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 32
- By:
- Publication type:
- Article
Complete remission of localised gastric plasmacytomas following definitive radiotherapy.
- Published in:
- Journal of Medical Imaging & Radiation Oncology, 2012, v. 56, n. 3, p. 328, doi. 10.1111/j.1754-9485.2012.02369.x
- By:
- Publication type:
- Article
Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n‐of‐1 trial of weekly‐interval red cell transfusion in myelodysplastic syndromes.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 236, doi. 10.1111/trf.17706
- By:
- Publication type:
- Article
N-Acetylcysteine for thrombotic thrombocytopenic purpura: is a von Willebrand factor-inhibitory dose feasible in vivo?
- Published in:
- Transfusion, 2014, v. 54, n. 9, p. 2362, doi. 10.1111/trf.12787
- By:
- Publication type:
- Article
Aplastic anaemia: autoimmune sequel of thymoma.
- Published in:
- 2009
- By:
- Publication type:
- Other
Bone marrow engraftment in pulmonary vessels.
- Published in:
- 2009
- By:
- Publication type:
- Other
Oxidative haemolysis due to ‘poppers’.
- Published in:
- 2008
- By:
- Publication type:
- Other